U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07008300) titled 'Safety, Tolerability, and Pharmacokinetics of an Oral Withania Somnifera Product in Older Adults' on May 27.
Brief Summary: This study will measure the oral bioavailability and pharmacokinetics of known compounds from a standardized Withania somnifera botanical dietary supplement in healthy older adults.
Study Start Date: April 08, 2024
Study Type: INTERVENTIONAL
Condition:
Healthy
Aging
Intervention:
DIETARY_SUPPLEMENT: Shoden
Shoden(R) powder is a commercial, dried 70% ethanolic extract of Withania somnifera (ashwagandha, WS) root and leaf, standardized to 35% withanolide glycosides. Shoden(R) powder is manufactured by Arjun...